B12, iron, folate, vitamin D, and magnesium are the most common deficiencies reported during GLP-1 therapy
The FDA has raised red flags about unapproved versions of these medications
The effect of Semaglutide on apoptosis of MOVAS in calcifiedenvironment (AGEs-BSA)
Avoiding hepatotoxic substances : This includes limiting acetaminophen to recommended doses (generally no more than 3,000 mg daily for adults
A 2022 study following 327 patients one year after discontinuing semaglutide treatment found that participants regained an average of two-thirds of the weight lost during treatment [5]
Key takeaways Wegovy is a GLP-1 medication that is prescribed to help with weight loss and weight management, to reduce cardiovascular risks, and to treat metabolic dysfunction-associated steatohepatitis (MASH)